# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Baird analyst Michael Ha maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $597 to ...
Morgan Stanley analyst Ricky Goldwasser maintains UnitedHealth Group (NYSE:UNH) with a Overweight and raises the price targe...
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, with the index remaining in the ...
Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, cer...
U.S. stocks are stubbornly holding onto their upward momentum, as evidenced by the gains for the index futures early Tuesday. T...
UnitedHealth surpasses Q2 2024 earnings expectations. The report highlights growth at Optum and UnitedHealthcare, and addresses...
The company currently estimates the total full year 2024 impact at $1.90 to $2.05 per share. Within this, direct response costs...